Request Deal Involvement
Frazier Life Sciences and Deep Track Capital led a $115m Series D funding in Maze Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
JP Morgan
pr advisors
1AB
legal advisors
Cooley
or
Principals
target
MAZE THERAPEUTICS
bidder
JANUS HENDERSON INVESTORS
bidder
ANDREESSEN HOROWITZ LLC (A16Z)
bidder
LOGOS CAPITAL
bidder
PIPER HEARTLAND HEALTHCARE CAPITAL
bidder
ARCH VENTURE PARTNERS
bidder
FRAZIER LIFE SCIENCES
bidder
GENERAL CATALYST PARTNERS
bidder
FORESITE CAPITAL MANAGEMENT LLC
bidder
WOODLINE PARTNERS
bidder
THIRD ROCK VENTURES LLC
bidder
DEEP TRACK CAPITAL
bidder
MATRIX CAPITAL MANAGEMENT
bidder
CASDIN CAPITAL
bidder
MOORE STRATEGIC VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite